Reveals bioenergetic states in mitochondria using atomic force microscopy, suggesting new ways to assess organelle function.
Mitochondria orchestrate energy conversion and cell fate, yet label-free approaches that report both functional and physical states at the single-organelle level are nonexistent. Here, we combine atomic force microscopy (AFM) imaging with single-mitochondrion phenotyping by quantifying stiffness, height, and spontaneous low-frequency height fluctuations at the nanoscale. Across respiratory activators, inhibitors, and uncouplers, the integrated 0- to 20-Hz fluctuation power correlates with mitochondrial membrane potential (ΔΨ m ) and does not covary with changes in mitochondrial height (a proxy for swelling). In liver mitochondria lacking mitochondrial carrier homolog 2 (MTCH2), a regulator of mitochondrial metabolism, dynamics, and apoptosis, AFM reveals a compact, mechanically stiff, high-fluctuation state consistent with hyperpolarization and distinct from inhibited/uncoupled signatures. Extending the assay to mitochondria isolated from mouse embryonic fibroblasts, AFM data can distinguish between genotypes: loss of the mitochondrial pro-fusion proteins mitofusin 1 or 2 ( MFN1 or MFN2 ) yields stiff, low-fluctuation mitochondria with reduced ΔΨ m , whereas MTCH2 loss produces stiff, high-fluctuation, high-ΔΨ m mitochondria. These three label-free features provide reproducible single-organelle “fingerprints” that resolve bioenergetic states and molecular defects and complement fluorescence and respirometry.
No takes yet. Share an insight, caveat, or question.
Zorikova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: